Chinese consumers concerned about protein intake, says Fonterra
Chinese consumers are aware of the need to increase protein intake to reduce the risk of developing conditions like sarcopenia, according to Fonterra Dairy Company.
Archives for December 21, 2011
Plant proteins, ‘pill fatigue’ and ‘abominable’ weight loss ads: A year in supplements…
Could 2012 be the year for canola protein to shine? Will a dietary solution to the ticking time bomb of type 2 diabetes finally make it big in the supplement aisles? And are gummies the solution to ‘pill fatigue’?
Inaccurate media coverage and misguided attempts at regulation? A year in consumer health advocacy …
We’ve spoken to the industry trade associations, but what are the priorities for health advocacy groups claiming to represent consumers’ interests when it comes to dietary supplements?
ABC: Solvents white paper could help inform NDI debate
An authoritative new guide to 23+solvents used in the production of botanical extracts for dietary ingredients could help inform the debate on ‘chemical alteration’ at the heart of the FDA’s draft guidance on new dietary ingredients (NDIs), says the...
Soy compounds may boost cancer treatment effectiveness: Mouse study
Oral supplementation with soy isoflavones could help to make radiation treatment of lung cancer tumours more effective while helping to preserve normal tissue, according to new research.
2012 set to see some heavyweight M&A activity? Definitely, say leading food market analysts
Is there appetite for M&A activity in 2012? Food market watchers reckon the sector could see some heavyweight deals next year despite the on-going credit lending challenges.
Yakult never presented the basic evidence for probiotic health claim, says consultant
Yakult failed to present the most basic evidence and sought a too-complicated immunity claim in the controversially rejected immunity health claim for its probiotic drinks, a UK consultant has said.
Beneo: Prebiotic health claim rejections have put prospects “on hold”
The second part of this exclusive interview sees Beneo executive board member, Yves Servotte, explaining the cooling but not crushing effect of EU prebiotic health claim rejections on its inulin-chicory business.